Table of Contents Table of Contents
Previous Page  89 / 1082 Next Page
Information
Show Menu
Previous Page 89 / 1082 Next Page
Page Background

S76

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

The systematic sensitivity study revealed the capability of

the PGI slit camera to detect range shifts under clinical

conditions. In both treatment modalities, global range

shifts can be detected. Additionally, in PBS a spot-wise

comparison allows also the determination of

interfractional local range shifts. Moreover, a still ongoing

evaluation of PBS measured and simulated spot-wise

profiles for absolute range verification will be presented.

OC-0154 Proton therapy patient selection for

oropharyngeal cancer patients: the impact of treatment

accuracy

M. Hoogeman

1

, S. Breedveld

1

, M. De Jong

2

, E.

Astreinidou

2

, L. Tans

1

, F. Keskin-Cambay

1

, R. Bijman

1

, S.

Krol

2

, S. Van de Water

1

, T. Arts

1

1

Erasmus MC Cancer Institute, Radiation Oncology,

Rotterdam, The Netherlands

2

Leids University Medical Center, Radiation Oncology,

Leiden, The Netherlands

Purpose or Objective

Comparative treatment planning including Normal Tissue

Complication Probability (NTCP) evaluation has been

proposed to select patients for proton therapy. NTCP,

however, does not only depend on the type of radiation

used, but also on the size of the safety margins or degree

of robustness needed to account for treatment-related

uncertainties. In this study, for the first time to our

knowledge, the impact of margins and robustness settings

to the selection of oropharyngeal cancer patients is

investigated using fully automated comparative treatment

planning.

Material and Methods

CT and contour data of 78 consecutive oropharyngeal

patients were imported in our in-house developed system

for automated treatment planning for Intensity-Modulated

photon (IMRT) and proton radiotherapy (IMPT). Treatment

plans were generated fully automatically for a

simultaneously integrated boost scheme prescribing 70

Gy

RBE

to the primary tumor and pathological lymph nodes

and 54.25 Gy

RBE

to the elective nodal areas in 35 fractions.

IMRT treatment plans were generated with a 0, 3, or 5mm

margin. IMPT 'minimax” robust optimized treatment plans

were generated for five different setup and range

robustness settings. Five validated NTCP models (see Fig.

1) proposed for IMPT patient selection were used in this

study. Following Dutch consensus guidelines, patients

were selected for IMPT if IMPT reduced NTCP by 10% or 5%

for a grade II or a grade III complication, respectively.

Results

In total 624 treatment plans were generated automatically

and approved by the authors. Figure 1 shows that the

percentage of patients selected for IMPT decreases with

increasing robustness setting for a given margin and also

decreases with decreasing margin for a given robustness

setting. In contrast to the size of the margin, the degree

of robustness has little impact on patient selection for

tube feeding dependence, which is the only grade III

complication. For the other complications the impact of

the degree of robustness setting is noticeably higher. For

patient-rated sticky saliva, nearly no patient is selected

for IMPT if robustness is included. If we consider high-

precision IMRT using a 3mm margin and high-precision

IMPT using a robustness setting of 3mm for setup and 3%

for range errors, most patients are selected for proton

therapy based on problems swallowing solid food (51.3%),

followed by tube feeding dependence (37.2%) and

decreased parotid flow (29.5%). Patient-rated sticky saliva

and patient-rated xerostomia contributed only with 1.3%

and 7.7% respectively.

Conclusion

This study shows that treatment accuracy cannot be

ignored in estimating the number of patients that will be

selected for proton therapy based on comparative

treatment planning and NTCP evaluation. We also

conclude that IMRT as well as IMPT should be optimized

for accuracy to ensure a sustainable use of proton therapy.

Proffered Papers: Imaging and image analysis

OC-0155 Automated lung tumour delineation in cine

MR images for image guided radiotherapy with an MR-

Linac

B. Eiben

1

, M.F. Fast

2

, M.J. Menten

2

, K. Bromma

2

, A.

Wetscherek

2

, D.J. Hawkes

1

, J.R. McClelland

1

, U. Oelfke

2

1

University College London, Centre for Medical Image

Computing, London, United Kingdom

2

The Institute of Cancer Research and The Royal Marsden

NHS Foundation Trust, Joint Department of Physics,

London, United Kingdom

Purpose or Objective

Respiratory-induced lung tumour movement is a

significant challenge for precise dose delivery during

radiotherapy. MR-Linac technology has the potential to

monitor tumour motion and deformation using

continuously acquired 2D cine MR images. In order to

target tumours in their current shape and position the

tumour outline must be established automatically. In this

study we compared four automatic contouring algorithms

that delineate the tumour in sequential cine MR images

based on manually contoured training images.

Material and Methods

Five 1 min 2D cine MR images (Fig. 1) were acquired for

two patients. Each sequence was split into a training set

of ten source images and a test set of about 100 images.

Method (1) is a multi-template matching, with a template

taken from each source image centred on the tumour. For

every test image the best position of each template is

evaluated and the most similar match is selected. Method

(2) uses a pulse-coupled neural network (PCNN) to improve

the grey-value contrast between tumour and healthy

tissue thus aiding the auto-contouring. The PCNN and

associated erosion and dilation parameters were trained

on the training sets using an accelerated particle swarm